Socks David A's Form 4 filing
Phathom Pharmaceuticals, Inc. (PHAT) · filed Aug 18, 2021
- Accession no.
- 0001209191-21-052287
- Filed
- Aug 18, 2021
- Trade date
- Aug 16, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $562.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Socks David ACIK 0001378847 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2021 | Common Stock | SSaleDisposed | −4,209 | $30.47 | −$128,248.23 | 1,261,137 | Indirect | |
| Aug 16, 2021 | Common Stock | SSaleDisposed | −13,791 | $31.49 | −$434,278.59 | 1,247,346 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.